Bain Capital Life Sciences said Tuesday it has secured about $3 billion for its fourth fund, bringing the private investment firm’s total haul since its 2016 inception to $6.7 billion. Bain Capital ...
The announced job cuts are the latest in a series of steps Bluebird has taken to preserve cash and break even financially amid slow uptake of its marketed gene therapies.
This funding boost will help Altamira progress their innovative pipeline while also supporting their ongoing divestment of legacy assets in allergology, viral infections, and inner ear disorders.
Organon shares have stabilized in recent times, with gradual debt reduction and structural growth allowing for a valuation re ...
Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...